Toward comprehensive value assessment for Alzheimer's disease innovations.

Introduction: Assessing medical technologies for Alzheimer's disease (AD) creates challenges for current methods of value assessment. New value assessment approaches for AD are also needed.

Methods: We adapted concepts from health economics to help guide decision makers to more informed decisions about AD therapies and diagnostics.